Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study

NCT04395742 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04395742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04395742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2020
Completion date
December 31, 2020
Enrollment
93 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019